Search | VHL Regional Portal

Efficacy of additional treatment for chronic spontaneous urticaria refractory to treatment - A single-center retrospective real-world study.

Ohata, Marie; Oda, Yoshiko; Washio, Ken; Fukunaga, Atsushi; Nishigori, Chikako.

J Dermatol ; 49(1): e7-e8, 2022 Jan.

Article in English | MEDLINE | ID: mdl-34632611

Subject(s)

Anti-Allergic Agents , Chronic Urticaria , Urticaria , Anti-Allergic Agents/therapeutic use , Chronic Disease , Humans , Omalizumab/therapeutic use , Retrospective Studies , Treatment Outcome , Urticaria/diagnosis , Urticaria/drug therapy

High prevalence of epilepsy in HAE with normal C1-INH.

Kuwahara, Saki; Fukunaga, Atsushi; Ohata, Marie; Nakatani, Shoko; Yokoyama, Daisuke; Nakauchi, Emi; Yoshioka, Ai; Kinoshita, Masako; Nishigori, Chikako.

Allergol Int ; 69(4): 630-632, 2020 Oct.

Article in English | MEDLINE | ID: mdl-32444305

Subject(s)

Angioedemas, Hereditary/complications , Angioedemas, Hereditary/epidemiology , Complement C1 Inhibitor Protein , Epilepsy/epidemiology , Epilepsy/etiology , Adult , Angioedemas, Hereditary/blood , Child, Preschool , Complement C1 Inhibitor Protein/genetics , Disease Susceptibility , Epilepsy/diagnosis , Female , Humans , Male , Middle Aged , Mutation , Prevalence

Agminated fibroblastic connective tissue nevus in a 1-year-old boy.

Ohata, Marie; Fujiwara, Susumu; Yoshioka, Ai; Nagai, Hiroshi; Sugita, Shintaro; Yamano, Nozomi; Inoue, Yusuke; Nishigori, Chikako.

Pediatr Dermatol ; 36(6): 997-998, 2019 Nov.

Article in English | MEDLINE | ID: mdl-31469926

ABSTRACT

Fibroblastic connective tissue nevus (FCTN) is a benign cutaneous mesenchymal lesion characterized by proliferation of CD34-positive fibroblastic/myofibroblastic spindle-shaped cells. We report a case of agminated FCTN on the right lower abdomen of a 1-year-old boy.

Subject(s)

Fibroblasts/pathology , Nevus/pathology , Skin Neoplasms/pathology , Abdomen , Humans , Infant , Male

Subject(s)

Subject(s)

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL